Plasmid DNA Manufacturing Services - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512247978

Publication Date:

December 4, 2024

Pages:

129

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Plasmid DNA manufacturing services refer to specialized processes offered by biotechnology companies to produce plasmid DNA at various scales and quantities. Plasmid DNA is a small, circular piece of DNA commonly used in biotechnology and genetic engineering applications, such as gene therapy, genetic research, vaccine development, and recombinant protein production.
The global market for Plasmid DNA Manufacturing Services was estimated to be worth US$ 1297.3 million in 2023 and is forecast to a readjusted size of US$ 3106.6 million by 2030 with a CAGR of 12.8% during the forecast period 2024-2030
The development and commercialization of gene editing technologies like CRISPR-Cas have increased the demand for high-quality plasmid DNA as essential tools for gene editing research and applications.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Plasmid DNA Manufacturing Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Plasmid DNA Manufacturing Services by region & country, by Type, and by Application.
The Plasmid DNA Manufacturing Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasmid DNA Manufacturing Services.
麻豆原创 Segmentation
By Company
Vigene Biosciences
Aldevron
Creative Biogene
Thermo Fisher Scientific Inc.
Kaneka Eurogentec SA
AGC Biologics
Andelyn Biosciences
Biomay
VGXI, Inc.
VectorBuilder
Xpress Biologics
Biovian
WuXi Advanced Therapies
Catalent, Inc
Charles River Laboratories
Esco Aster Pte. Ltd
Waisman
Boehringer Ingelheim Biopharmaceuticals GmbH
Segment by Type:
Research-Grade Plasmids
High Quality (HQ) / GMP-Ready鈩� Plasmids
CGMP Plasmid
Others
Segment by Application
Medical Industry
Biological Industry
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Plasmid DNA Manufacturing Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Plasmid DNA Manufacturing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Plasmid DNA Manufacturing Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Plasmid DNA Manufacturing Services Product Introduction
1.2 Global Plasmid DNA Manufacturing Services 麻豆原创 Size Forecast
1.3 Plasmid DNA Manufacturing Services 麻豆原创 Trends & Drivers
1.3.1 Plasmid DNA Manufacturing Services Industry Trends
1.3.2 Plasmid DNA Manufacturing Services 麻豆原创 Drivers & Opportunity
1.3.3 Plasmid DNA Manufacturing Services 麻豆原创 Challenges
1.3.4 Plasmid DNA Manufacturing Services 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Plasmid DNA Manufacturing Services Players Revenue Ranking (2023)
2.2 Global Plasmid DNA Manufacturing Services Revenue by Company (2019-2024)
2.3 Key Companies Plasmid DNA Manufacturing Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Plasmid DNA Manufacturing Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Plasmid DNA Manufacturing Services
2.6 Plasmid DNA Manufacturing Services 麻豆原创 Competitive Analysis
2.6.1 Plasmid DNA Manufacturing Services 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Plasmid DNA Manufacturing Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid DNA Manufacturing Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Research-Grade Plasmids
3.1.2 High Quality (HQ) / GMP-Ready鈩� Plasmids
3.1.3 CGMP Plasmid
3.1.4 Others
3.2 Global Plasmid DNA Manufacturing Services Sales Value by Type
3.2.1 Global Plasmid DNA Manufacturing Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Plasmid DNA Manufacturing Services Sales Value, by Type (2019-2030)
3.2.3 Global Plasmid DNA Manufacturing Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medical Industry
4.1.2 Biological Industry
4.1.3 Others
4.2 Global Plasmid DNA Manufacturing Services Sales Value by Application
4.2.1 Global Plasmid DNA Manufacturing Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Plasmid DNA Manufacturing Services Sales Value, by Application (2019-2030)
4.2.3 Global Plasmid DNA Manufacturing Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Plasmid DNA Manufacturing Services Sales Value by Region
5.1.1 Global Plasmid DNA Manufacturing Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Plasmid DNA Manufacturing Services Sales Value by Region (2019-2024)
5.1.3 Global Plasmid DNA Manufacturing Services Sales Value by Region (2025-2030)
5.1.4 Global Plasmid DNA Manufacturing Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Plasmid DNA Manufacturing Services Sales Value, 2019-2030
5.2.2 North America Plasmid DNA Manufacturing Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Plasmid DNA Manufacturing Services Sales Value, 2019-2030
5.3.2 Europe Plasmid DNA Manufacturing Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Plasmid DNA Manufacturing Services Sales Value, 2019-2030
5.4.2 Asia Pacific Plasmid DNA Manufacturing Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Plasmid DNA Manufacturing Services Sales Value, 2019-2030
5.5.2 South America Plasmid DNA Manufacturing Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Plasmid DNA Manufacturing Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Plasmid DNA Manufacturing Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Plasmid DNA Manufacturing Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Plasmid DNA Manufacturing Services Sales Value
6.3 United States
6.3.1 United States Plasmid DNA Manufacturing Services Sales Value, 2019-2030
6.3.2 United States Plasmid DNA Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Plasmid DNA Manufacturing Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Plasmid DNA Manufacturing Services Sales Value, 2019-2030
6.4.2 Europe Plasmid DNA Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Plasmid DNA Manufacturing Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Plasmid DNA Manufacturing Services Sales Value, 2019-2030
6.5.2 China Plasmid DNA Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Plasmid DNA Manufacturing Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Plasmid DNA Manufacturing Services Sales Value, 2019-2030
6.6.2 Japan Plasmid DNA Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Plasmid DNA Manufacturing Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Plasmid DNA Manufacturing Services Sales Value, 2019-2030
6.7.2 South Korea Plasmid DNA Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Plasmid DNA Manufacturing Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Plasmid DNA Manufacturing Services Sales Value, 2019-2030
6.8.2 Southeast Asia Plasmid DNA Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Plasmid DNA Manufacturing Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Plasmid DNA Manufacturing Services Sales Value, 2019-2030
6.9.2 India Plasmid DNA Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Plasmid DNA Manufacturing Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Vigene Biosciences
7.1.1 Vigene Biosciences Profile
7.1.2 Vigene Biosciences Main Business
7.1.3 Vigene Biosciences Plasmid DNA Manufacturing Services Products, Services and Solutions
7.1.4 Vigene Biosciences Plasmid DNA Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.1.5 Vigene Biosciences Recent Developments
7.2 Aldevron
7.2.1 Aldevron Profile
7.2.2 Aldevron Main Business
7.2.3 Aldevron Plasmid DNA Manufacturing Services Products, Services and Solutions
7.2.4 Aldevron Plasmid DNA Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.2.5 Aldevron Recent Developments
7.3 Creative Biogene
7.3.1 Creative Biogene Profile
7.3.2 Creative Biogene Main Business
7.3.3 Creative Biogene Plasmid DNA Manufacturing Services Products, Services and Solutions
7.3.4 Creative Biogene Plasmid DNA Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.3.5 Thermo Fisher Scientific Inc. Recent Developments
7.4 Thermo Fisher Scientific Inc.
7.4.1 Thermo Fisher Scientific Inc. Profile
7.4.2 Thermo Fisher Scientific Inc. Main Business
7.4.3 Thermo Fisher Scientific Inc. Plasmid DNA Manufacturing Services Products, Services and Solutions
7.4.4 Thermo Fisher Scientific Inc. Plasmid DNA Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.4.5 Thermo Fisher Scientific Inc. Recent Developments
7.5 Kaneka Eurogentec SA
7.5.1 Kaneka Eurogentec SA Profile
7.5.2 Kaneka Eurogentec SA Main Business
7.5.3 Kaneka Eurogentec SA Plasmid DNA Manufacturing Services Products, Services and Solutions
7.5.4 Kaneka Eurogentec SA Plasmid DNA Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.5.5 Kaneka Eurogentec SA Recent Developments
7.6 AGC Biologics
7.6.1 AGC Biologics Profile
7.6.2 AGC Biologics Main Business
7.6.3 AGC Biologics Plasmid DNA Manufacturing Services Products, Services and Solutions
7.6.4 AGC Biologics Plasmid DNA Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.6.5 AGC Biologics Recent Developments
7.7 Andelyn Biosciences
7.7.1 Andelyn Biosciences Profile
7.7.2 Andelyn Biosciences Main Business
7.7.3 Andelyn Biosciences Plasmid DNA Manufacturing Services Products, Services and Solutions
7.7.4 Andelyn Biosciences Plasmid DNA Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.7.5 Andelyn Biosciences Recent Developments
7.8 Biomay
7.8.1 Biomay Profile
7.8.2 Biomay Main Business
7.8.3 Biomay Plasmid DNA Manufacturing Services Products, Services and Solutions
7.8.4 Biomay Plasmid DNA Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.8.5 Biomay Recent Developments
7.9 VGXI, Inc.
7.9.1 VGXI, Inc. Profile
7.9.2 VGXI, Inc. Main Business
7.9.3 VGXI, Inc. Plasmid DNA Manufacturing Services Products, Services and Solutions
7.9.4 VGXI, Inc. Plasmid DNA Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.9.5 VGXI, Inc. Recent Developments
7.10 VectorBuilder
7.10.1 VectorBuilder Profile
7.10.2 VectorBuilder Main Business
7.10.3 VectorBuilder Plasmid DNA Manufacturing Services Products, Services and Solutions
7.10.4 VectorBuilder Plasmid DNA Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.10.5 VectorBuilder Recent Developments
7.11 Xpress Biologics
7.11.1 Xpress Biologics Profile
7.11.2 Xpress Biologics Main Business
7.11.3 Xpress Biologics Plasmid DNA Manufacturing Services Products, Services and Solutions
7.11.4 Xpress Biologics Plasmid DNA Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.11.5 Xpress Biologics Recent Developments
7.12 Biovian
7.12.1 Biovian Profile
7.12.2 Biovian Main Business
7.12.3 Biovian Plasmid DNA Manufacturing Services Products, Services and Solutions
7.12.4 Biovian Plasmid DNA Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.12.5 Biovian Recent Developments
7.13 WuXi Advanced Therapies
7.13.1 WuXi Advanced Therapies Profile
7.13.2 WuXi Advanced Therapies Main Business
7.13.3 WuXi Advanced Therapies Plasmid DNA Manufacturing Services Products, Services and Solutions
7.13.4 WuXi Advanced Therapies Plasmid DNA Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.13.5 WuXi Advanced Therapies Recent Developments
7.14 Catalent, Inc
7.14.1 Catalent, Inc Profile
7.14.2 Catalent, Inc Main Business
7.14.3 Catalent, Inc Plasmid DNA Manufacturing Services Products, Services and Solutions
7.14.4 Catalent, Inc Plasmid DNA Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.14.5 Catalent, Inc Recent Developments
7.15 Charles River Laboratories
7.15.1 Charles River Laboratories Profile
7.15.2 Charles River Laboratories Main Business
7.15.3 Charles River Laboratories Plasmid DNA Manufacturing Services Products, Services and Solutions
7.15.4 Charles River Laboratories Plasmid DNA Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.15.5 Charles River Laboratories Recent Developments
7.16 Esco Aster Pte. Ltd
7.16.1 Esco Aster Pte. Ltd Profile
7.16.2 Esco Aster Pte. Ltd Main Business
7.16.3 Esco Aster Pte. Ltd Plasmid DNA Manufacturing Services Products, Services and Solutions
7.16.4 Esco Aster Pte. Ltd Plasmid DNA Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.16.5 Esco Aster Pte. Ltd Recent Developments
7.17 Waisman
7.17.1 Waisman Profile
7.17.2 Waisman Main Business
7.17.3 Waisman Plasmid DNA Manufacturing Services Products, Services and Solutions
7.17.4 Waisman Plasmid DNA Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.17.5 Waisman Recent Developments
7.18 Boehringer Ingelheim Biopharmaceuticals GmbH
7.18.1 Boehringer Ingelheim Biopharmaceuticals GmbH Profile
7.18.2 Boehringer Ingelheim Biopharmaceuticals GmbH Main Business
7.18.3 Boehringer Ingelheim Biopharmaceuticals GmbH Plasmid DNA Manufacturing Services Products, Services and Solutions
7.18.4 Boehringer Ingelheim Biopharmaceuticals GmbH Plasmid DNA Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.18.5 Boehringer Ingelheim Biopharmaceuticals GmbH Recent Developments
8 Industry Chain Analysis
8.1 Plasmid DNA Manufacturing Services Industrial Chain
8.2 Plasmid DNA Manufacturing Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Plasmid DNA Manufacturing Services Sales Model
8.5.2 Sales Channel
8.5.3 Plasmid DNA Manufacturing Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Vigene Biosciences
Aldevron
Creative Biogene
Thermo Fisher Scientific Inc.
Kaneka Eurogentec SA
AGC Biologics
Andelyn Biosciences
Biomay
VGXI, Inc.
VectorBuilder
Xpress Biologics
Biovian
WuXi Advanced Therapies
Catalent, Inc
Charles River Laboratories
Esco Aster Pte. Ltd
Waisman
Boehringer Ingelheim Biopharmaceuticals GmbH

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.